-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Atea Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2018 to 2023.
- Atea Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$31.2M, a 6.01% increase year-over-year.
- Atea Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$174M, a 32.6% decline year-over-year.
- Atea Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$136M, a 17.3% decline from 2022.
- Atea Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$116M, a 196% decline from 2021.
- Atea Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $121M.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)